0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antiviral and Antibacterial Textiles Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-15D18330
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Antiviral and Antibacterial Textiles Market Research Report 2024
BUY CHAPTERS

Global Antiviral and Antibacterial Textiles Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-15D18330
Report
October 2025
Pages:203
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antiviral and Antibacterial Textiles Market

The global Antiviral and Antibacterial Textiles market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Antiviral and antimicrobial textiles refer to textiles that have been specially treated or made from special materials, designed to reduce or inhibit the survival and spread of bacteria and viruses on the fabric surface. These textiles are widely used in various fields such as medical applications, personal protective equipment, everyday clothing, and household items.
From a downstream perspective, Daily Necessity accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Antiviral and Antibacterial Textiles leading manufacturers including Foss Manufacturing, Acordis, Fuji, Trevira GmbH, Sotexpro, Toray, BioCote, Milliken & Company, UNITIKA, PurThread Technologies, etc., dominate supply; the top five capture approximately % of global revenue, with Foss Manufacturing leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Antiviral and Antibacterial Textiles market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Antiviral and Antibacterial Textiles Market Report

Report Metric Details
Report Name Antiviral and Antibacterial Textiles Market
Segment by Type
  • Inorganic
  • Organic
Segment by Application
  • Daily Necessity
  • Clothing
  • Medical
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Foss Manufacturing, Acordis, Fuji, Trevira GmbH, Sotexpro, Toray, BioCote, Milliken & Company, UNITIKA, PurThread Technologies, NBC Meshtec, Microban, Sanitized AG, Noble Biomaterials, HeiQ Materials AG, Teijin, Nippon Shokubai, BASF, Murata, Dow, ANNIL, Bioserica Era, Qianhai Guangda, Ruyi Woolen Garment Group, Jiangsu Jonnyma New Materials, Zhong Wang Fabric, Taihua New Material, Lu Thai Textile, Fynex Textile
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Antiviral and Antibacterial Textiles study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Antiviral and Antibacterial Textiles Market report?

Ans: The main players in the Antiviral and Antibacterial Textiles Market are Foss Manufacturing, Acordis, Fuji, Trevira GmbH, Sotexpro, Toray, BioCote, Milliken & Company, UNITIKA, PurThread Technologies, NBC Meshtec, Microban, Sanitized AG, Noble Biomaterials, HeiQ Materials AG, Teijin, Nippon Shokubai, BASF, Murata, Dow, ANNIL, Bioserica Era, Qianhai Guangda, Ruyi Woolen Garment Group, Jiangsu Jonnyma New Materials, Zhong Wang Fabric, Taihua New Material, Lu Thai Textile, Fynex Textile

What are the Application segmentation covered in the Antiviral and Antibacterial Textiles Market report?

Ans: The Applications covered in the Antiviral and Antibacterial Textiles Market report are Daily Necessity, Clothing, Medical, Others

What are the Type segmentation covered in the Antiviral and Antibacterial Textiles Market report?

Ans: The Types covered in the Antiviral and Antibacterial Textiles Market report are Inorganic, Organic

1 Study Coverage
1.1 Introduction to Antiviral and Antibacterial Textiles: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Antiviral and Antibacterial Textiles Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Inorganic
1.2.3 Organic
1.3 Market Segmentation by Application
1.3.1 Global Antiviral and Antibacterial Textiles Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Daily Necessity
1.3.3 Clothing
1.3.4 Medical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antiviral and Antibacterial Textiles Revenue Estimates and Forecasts 2020-2031
2.2 Global Antiviral and Antibacterial Textiles Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Antiviral and Antibacterial Textiles Sales Estimates and Forecasts 2020-2031
2.4 Global Antiviral and Antibacterial Textiles Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Antiviral and Antibacterial Textiles Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Antiviral and Antibacterial Textiles Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Antiviral and Antibacterial Textiles Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Inorganic Market Size by Manufacturers
4.5.2 Organic Market Size by Manufacturers
4.6 Global Antiviral and Antibacterial Textiles Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Antiviral and Antibacterial Textiles Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Antiviral and Antibacterial Textiles Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Antiviral and Antibacterial Textiles Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Antiviral and Antibacterial Textiles Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
7.4 North America Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Antiviral and Antibacterial Textiles Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
8.4 Europe Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Antiviral and Antibacterial Textiles Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Antiviral and Antibacterial Textiles Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
10.4 Central and South America Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Antiviral and Antibacterial Textiles Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Antiviral and Antibacterial Textiles Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Foss Manufacturing
12.1.1 Foss Manufacturing Corporation Information
12.1.2 Foss Manufacturing Business Overview
12.1.3 Foss Manufacturing Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.1.4 Foss Manufacturing Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Foss Manufacturing Antiviral and Antibacterial Textiles Sales by Product in 2024
12.1.6 Foss Manufacturing Antiviral and Antibacterial Textiles Sales by Application in 2024
12.1.7 Foss Manufacturing Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.1.8 Foss Manufacturing Antiviral and Antibacterial Textiles SWOT Analysis
12.1.9 Foss Manufacturing Recent Developments
12.2 Acordis
12.2.1 Acordis Corporation Information
12.2.2 Acordis Business Overview
12.2.3 Acordis Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.2.4 Acordis Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Acordis Antiviral and Antibacterial Textiles Sales by Product in 2024
12.2.6 Acordis Antiviral and Antibacterial Textiles Sales by Application in 2024
12.2.7 Acordis Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.2.8 Acordis Antiviral and Antibacterial Textiles SWOT Analysis
12.2.9 Acordis Recent Developments
12.3 Fuji
12.3.1 Fuji Corporation Information
12.3.2 Fuji Business Overview
12.3.3 Fuji Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.3.4 Fuji Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Fuji Antiviral and Antibacterial Textiles Sales by Product in 2024
12.3.6 Fuji Antiviral and Antibacterial Textiles Sales by Application in 2024
12.3.7 Fuji Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.3.8 Fuji Antiviral and Antibacterial Textiles SWOT Analysis
12.3.9 Fuji Recent Developments
12.4 Trevira GmbH
12.4.1 Trevira GmbH Corporation Information
12.4.2 Trevira GmbH Business Overview
12.4.3 Trevira GmbH Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.4.4 Trevira GmbH Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Trevira GmbH Antiviral and Antibacterial Textiles Sales by Product in 2024
12.4.6 Trevira GmbH Antiviral and Antibacterial Textiles Sales by Application in 2024
12.4.7 Trevira GmbH Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.4.8 Trevira GmbH Antiviral and Antibacterial Textiles SWOT Analysis
12.4.9 Trevira GmbH Recent Developments
12.5 Sotexpro
12.5.1 Sotexpro Corporation Information
12.5.2 Sotexpro Business Overview
12.5.3 Sotexpro Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.5.4 Sotexpro Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Sotexpro Antiviral and Antibacterial Textiles Sales by Product in 2024
12.5.6 Sotexpro Antiviral and Antibacterial Textiles Sales by Application in 2024
12.5.7 Sotexpro Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.5.8 Sotexpro Antiviral and Antibacterial Textiles SWOT Analysis
12.5.9 Sotexpro Recent Developments
12.6 Toray
12.6.1 Toray Corporation Information
12.6.2 Toray Business Overview
12.6.3 Toray Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.6.4 Toray Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Toray Recent Developments
12.7 BioCote
12.7.1 BioCote Corporation Information
12.7.2 BioCote Business Overview
12.7.3 BioCote Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.7.4 BioCote Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 BioCote Recent Developments
12.8 Milliken & Company
12.8.1 Milliken & Company Corporation Information
12.8.2 Milliken & Company Business Overview
12.8.3 Milliken & Company Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.8.4 Milliken & Company Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Milliken & Company Recent Developments
12.9 UNITIKA
12.9.1 UNITIKA Corporation Information
12.9.2 UNITIKA Business Overview
12.9.3 UNITIKA Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.9.4 UNITIKA Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 UNITIKA Recent Developments
12.10 PurThread Technologies
12.10.1 PurThread Technologies Corporation Information
12.10.2 PurThread Technologies Business Overview
12.10.3 PurThread Technologies Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.10.4 PurThread Technologies Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 PurThread Technologies Recent Developments
12.11 NBC Meshtec
12.11.1 NBC Meshtec Corporation Information
12.11.2 NBC Meshtec Business Overview
12.11.3 NBC Meshtec Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.11.4 NBC Meshtec Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 NBC Meshtec Recent Developments
12.12 Microban
12.12.1 Microban Corporation Information
12.12.2 Microban Business Overview
12.12.3 Microban Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.12.4 Microban Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Microban Recent Developments
12.13 Sanitized AG
12.13.1 Sanitized AG Corporation Information
12.13.2 Sanitized AG Business Overview
12.13.3 Sanitized AG Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.13.4 Sanitized AG Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Sanitized AG Recent Developments
12.14 Noble Biomaterials
12.14.1 Noble Biomaterials Corporation Information
12.14.2 Noble Biomaterials Business Overview
12.14.3 Noble Biomaterials Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.14.4 Noble Biomaterials Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 Noble Biomaterials Recent Developments
12.15 HeiQ Materials AG
12.15.1 HeiQ Materials AG Corporation Information
12.15.2 HeiQ Materials AG Business Overview
12.15.3 HeiQ Materials AG Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.15.4 HeiQ Materials AG Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 HeiQ Materials AG Recent Developments
12.16 Teijin
12.16.1 Teijin Corporation Information
12.16.2 Teijin Business Overview
12.16.3 Teijin Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.16.4 Teijin Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 Teijin Recent Developments
12.17 Nippon Shokubai
12.17.1 Nippon Shokubai Corporation Information
12.17.2 Nippon Shokubai Business Overview
12.17.3 Nippon Shokubai Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.17.4 Nippon Shokubai Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.17.5 Nippon Shokubai Recent Developments
12.18 BASF
12.18.1 BASF Corporation Information
12.18.2 BASF Business Overview
12.18.3 BASF Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.18.4 BASF Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.18.5 BASF Recent Developments
12.19 Murata
12.19.1 Murata Corporation Information
12.19.2 Murata Business Overview
12.19.3 Murata Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.19.4 Murata Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.19.5 Murata Recent Developments
12.20 Dow
12.20.1 Dow Corporation Information
12.20.2 Dow Business Overview
12.20.3 Dow Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.20.4 Dow Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.20.5 Dow Recent Developments
12.21 ANNIL
12.21.1 ANNIL Corporation Information
12.21.2 ANNIL Business Overview
12.21.3 ANNIL Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.21.4 ANNIL Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.21.5 ANNIL Recent Developments
12.22 Bioserica Era
12.22.1 Bioserica Era Corporation Information
12.22.2 Bioserica Era Business Overview
12.22.3 Bioserica Era Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.22.4 Bioserica Era Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.22.5 Bioserica Era Recent Developments
12.23 Qianhai Guangda
12.23.1 Qianhai Guangda Corporation Information
12.23.2 Qianhai Guangda Business Overview
12.23.3 Qianhai Guangda Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.23.4 Qianhai Guangda Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.23.5 Qianhai Guangda Recent Developments
12.24 Ruyi Woolen Garment Group
12.24.1 Ruyi Woolen Garment Group Corporation Information
12.24.2 Ruyi Woolen Garment Group Business Overview
12.24.3 Ruyi Woolen Garment Group Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.24.4 Ruyi Woolen Garment Group Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.24.5 Ruyi Woolen Garment Group Recent Developments
12.25 Jiangsu Jonnyma New Materials
12.25.1 Jiangsu Jonnyma New Materials Corporation Information
12.25.2 Jiangsu Jonnyma New Materials Business Overview
12.25.3 Jiangsu Jonnyma New Materials Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.25.4 Jiangsu Jonnyma New Materials Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.25.5 Jiangsu Jonnyma New Materials Recent Developments
12.26 Zhong Wang Fabric
12.26.1 Zhong Wang Fabric Corporation Information
12.26.2 Zhong Wang Fabric Business Overview
12.26.3 Zhong Wang Fabric Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.26.4 Zhong Wang Fabric Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.26.5 Zhong Wang Fabric Recent Developments
12.27 Taihua New Material
12.27.1 Taihua New Material Corporation Information
12.27.2 Taihua New Material Business Overview
12.27.3 Taihua New Material Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.27.4 Taihua New Material Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.27.5 Taihua New Material Recent Developments
12.28 Lu Thai Textile
12.28.1 Lu Thai Textile Corporation Information
12.28.2 Lu Thai Textile Business Overview
12.28.3 Lu Thai Textile Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.28.4 Lu Thai Textile Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.28.5 Lu Thai Textile Recent Developments
12.29 Fynex Textile
12.29.1 Fynex Textile Corporation Information
12.29.2 Fynex Textile Business Overview
12.29.3 Fynex Textile Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.29.4 Fynex Textile Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.29.5 Fynex Textile Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Antiviral and Antibacterial Textiles Industry Chain
13.2 Antiviral and Antibacterial Textiles Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Antiviral and Antibacterial Textiles Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Antiviral and Antibacterial Textiles Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Antiviral and Antibacterial Textiles Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Antiviral and Antibacterial Textiles Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Antiviral and Antibacterial Textiles Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Antiviral and Antibacterial Textiles Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Antiviral and Antibacterial Textiles Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Antiviral and Antibacterial Textiles Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Antiviral and Antibacterial Textiles Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Antiviral and Antibacterial Textiles Sales by Region (2020-2025) & (Tons)
 Table 8. Global Antiviral and Antibacterial Textiles Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Antiviral and Antibacterial Textiles Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Antiviral and Antibacterial Textiles Production by Region (2020-2025) & (Tons)
 Table 12. Global Antiviral and Antibacterial Textiles Production by Region (2026-2031) & (Tons)
 Table 13. Global Antiviral and Antibacterial Textiles Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Antiviral and Antibacterial Textiles Sales Share by Manufacturers (2020-2025)
 Table 15. Global Antiviral and Antibacterial Textiles Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Antiviral and Antibacterial Textiles Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Antiviral and Antibacterial Textiles by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral and Antibacterial Textiles as of 2024)
 Table 19. Global Antiviral and Antibacterial Textiles Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Antiviral and Antibacterial Textiles Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Antiviral and Antibacterial Textiles Manufacturing Base and Headquarters
 Table 22. Global Antiviral and Antibacterial Textiles Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Antiviral and Antibacterial Textiles Sales by Type (2020-2025) & (Tons)
 Table 26. Global Antiviral and Antibacterial Textiles Sales by Type (2026-2031) & (Tons)
 Table 27. Global Antiviral and Antibacterial Textiles Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Antiviral and Antibacterial Textiles Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Antiviral and Antibacterial Textiles ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Antiviral and Antibacterial Textiles Sales by Application (2020-2025) & (Tons)
 Table 32. Global Antiviral and Antibacterial Textiles Sales by Application (2026-2031) & (Tons)
 Table 33. Antiviral and Antibacterial Textiles High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Antiviral and Antibacterial Textiles Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Antiviral and Antibacterial Textiles Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Antiviral and Antibacterial Textiles ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Antiviral and Antibacterial Textiles Growth Accelerators and Market Barriers
 Table 40. North America Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Antiviral and Antibacterial Textiles Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Antiviral and Antibacterial Textiles Growth Accelerators and Market Barriers
 Table 43. Europe Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Antiviral and Antibacterial Textiles Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Antiviral and Antibacterial Textiles Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Antiviral and Antibacterial Textiles Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Antiviral and Antibacterial Textiles Investment Opportunities and Key Challenges
 Table 50. Central and South America Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Antiviral and Antibacterial Textiles Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Antiviral and Antibacterial Textiles Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Foss Manufacturing Corporation Information
 Table 54. Foss Manufacturing Description and Major Businesses
 Table 55. Foss Manufacturing Product Models, Descriptions and Specifications
 Table 56. Foss Manufacturing Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Foss Manufacturing Sales Value Proportion by Product in 2024
 Table 58. Foss Manufacturing Sales Value Proportion by Application in 2024
 Table 59. Foss Manufacturing Sales Value Proportion by Geographic Area in 2024
 Table 60. Foss Manufacturing Antiviral and Antibacterial Textiles SWOT Analysis
 Table 61. Foss Manufacturing Recent Developments
 Table 62. Acordis Corporation Information
 Table 63. Acordis Description and Major Businesses
 Table 64. Acordis Product Models, Descriptions and Specifications
 Table 65. Acordis Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Acordis Sales Value Proportion by Product in 2024
 Table 67. Acordis Sales Value Proportion by Application in 2024
 Table 68. Acordis Sales Value Proportion by Geographic Area in 2024
 Table 69. Acordis Antiviral and Antibacterial Textiles SWOT Analysis
 Table 70. Acordis Recent Developments
 Table 71. Fuji Corporation Information
 Table 72. Fuji Description and Major Businesses
 Table 73. Fuji Product Models, Descriptions and Specifications
 Table 74. Fuji Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Fuji Sales Value Proportion by Product in 2024
 Table 76. Fuji Sales Value Proportion by Application in 2024
 Table 77. Fuji Sales Value Proportion by Geographic Area in 2024
 Table 78. Fuji Antiviral and Antibacterial Textiles SWOT Analysis
 Table 79. Fuji Recent Developments
 Table 80. Trevira GmbH Corporation Information
 Table 81. Trevira GmbH Description and Major Businesses
 Table 82. Trevira GmbH Product Models, Descriptions and Specifications
 Table 83. Trevira GmbH Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Trevira GmbH Sales Value Proportion by Product in 2024
 Table 85. Trevira GmbH Sales Value Proportion by Application in 2024
 Table 86. Trevira GmbH Sales Value Proportion by Geographic Area in 2024
 Table 87. Trevira GmbH Antiviral and Antibacterial Textiles SWOT Analysis
 Table 88. Trevira GmbH Recent Developments
 Table 89. Sotexpro Corporation Information
 Table 90. Sotexpro Description and Major Businesses
 Table 91. Sotexpro Product Models, Descriptions and Specifications
 Table 92. Sotexpro Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Sotexpro Sales Value Proportion by Product in 2024
 Table 94. Sotexpro Sales Value Proportion by Application in 2024
 Table 95. Sotexpro Sales Value Proportion by Geographic Area in 2024
 Table 96. Sotexpro Antiviral and Antibacterial Textiles SWOT Analysis
 Table 97. Sotexpro Recent Developments
 Table 98. Toray Corporation Information
 Table 99. Toray Description and Major Businesses
 Table 100. Toray Product Models, Descriptions and Specifications
 Table 101. Toray Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Toray Recent Developments
 Table 103. BioCote Corporation Information
 Table 104. BioCote Description and Major Businesses
 Table 105. BioCote Product Models, Descriptions and Specifications
 Table 106. BioCote Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. BioCote Recent Developments
 Table 108. Milliken & Company Corporation Information
 Table 109. Milliken & Company Description and Major Businesses
 Table 110. Milliken & Company Product Models, Descriptions and Specifications
 Table 111. Milliken & Company Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Milliken & Company Recent Developments
 Table 113. UNITIKA Corporation Information
 Table 114. UNITIKA Description and Major Businesses
 Table 115. UNITIKA Product Models, Descriptions and Specifications
 Table 116. UNITIKA Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. UNITIKA Recent Developments
 Table 118. PurThread Technologies Corporation Information
 Table 119. PurThread Technologies Description and Major Businesses
 Table 120. PurThread Technologies Product Models, Descriptions and Specifications
 Table 121. PurThread Technologies Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. PurThread Technologies Recent Developments
 Table 123. NBC Meshtec Corporation Information
 Table 124. NBC Meshtec Description and Major Businesses
 Table 125. NBC Meshtec Product Models, Descriptions and Specifications
 Table 126. NBC Meshtec Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. NBC Meshtec Recent Developments
 Table 128. Microban Corporation Information
 Table 129. Microban Description and Major Businesses
 Table 130. Microban Product Models, Descriptions and Specifications
 Table 131. Microban Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 132. Microban Recent Developments
 Table 133. Sanitized AG Corporation Information
 Table 134. Sanitized AG Description and Major Businesses
 Table 135. Sanitized AG Product Models, Descriptions and Specifications
 Table 136. Sanitized AG Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 137. Sanitized AG Recent Developments
 Table 138. Noble Biomaterials Corporation Information
 Table 139. Noble Biomaterials Description and Major Businesses
 Table 140. Noble Biomaterials Product Models, Descriptions and Specifications
 Table 141. Noble Biomaterials Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 142. Noble Biomaterials Recent Developments
 Table 143. HeiQ Materials AG Corporation Information
 Table 144. HeiQ Materials AG Description and Major Businesses
 Table 145. HeiQ Materials AG Product Models, Descriptions and Specifications
 Table 146. HeiQ Materials AG Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 147. HeiQ Materials AG Recent Developments
 Table 148. Teijin Corporation Information
 Table 149. Teijin Description and Major Businesses
 Table 150. Teijin Product Models, Descriptions and Specifications
 Table 151. Teijin Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 152. Teijin Recent Developments
 Table 153. Nippon Shokubai Corporation Information
 Table 154. Nippon Shokubai Description and Major Businesses
 Table 155. Nippon Shokubai Product Models, Descriptions and Specifications
 Table 156. Nippon Shokubai Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 157. Nippon Shokubai Recent Developments
 Table 158. BASF Corporation Information
 Table 159. BASF Description and Major Businesses
 Table 160. BASF Product Models, Descriptions and Specifications
 Table 161. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 162. BASF Recent Developments
 Table 163. Murata Corporation Information
 Table 164. Murata Description and Major Businesses
 Table 165. Murata Product Models, Descriptions and Specifications
 Table 166. Murata Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 167. Murata Recent Developments
 Table 168. Dow Corporation Information
 Table 169. Dow Description and Major Businesses
 Table 170. Dow Product Models, Descriptions and Specifications
 Table 171. Dow Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 172. Dow Recent Developments
 Table 173. ANNIL Corporation Information
 Table 174. ANNIL Description and Major Businesses
 Table 175. ANNIL Product Models, Descriptions and Specifications
 Table 176. ANNIL Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 177. ANNIL Recent Developments
 Table 178. Bioserica Era Corporation Information
 Table 179. Bioserica Era Description and Major Businesses
 Table 180. Bioserica Era Product Models, Descriptions and Specifications
 Table 181. Bioserica Era Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 182. Bioserica Era Recent Developments
 Table 183. Qianhai Guangda Corporation Information
 Table 184. Qianhai Guangda Description and Major Businesses
 Table 185. Qianhai Guangda Product Models, Descriptions and Specifications
 Table 186. Qianhai Guangda Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 187. Qianhai Guangda Recent Developments
 Table 188. Ruyi Woolen Garment Group Corporation Information
 Table 189. Ruyi Woolen Garment Group Description and Major Businesses
 Table 190. Ruyi Woolen Garment Group Product Models, Descriptions and Specifications
 Table 191. Ruyi Woolen Garment Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 192. Ruyi Woolen Garment Group Recent Developments
 Table 193. Jiangsu Jonnyma New Materials Corporation Information
 Table 194. Jiangsu Jonnyma New Materials Description and Major Businesses
 Table 195. Jiangsu Jonnyma New Materials Product Models, Descriptions and Specifications
 Table 196. Jiangsu Jonnyma New Materials Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 197. Jiangsu Jonnyma New Materials Recent Developments
 Table 198. Zhong Wang Fabric Corporation Information
 Table 199. Zhong Wang Fabric Description and Major Businesses
 Table 200. Zhong Wang Fabric Product Models, Descriptions and Specifications
 Table 201. Zhong Wang Fabric Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 202. Zhong Wang Fabric Recent Developments
 Table 203. Taihua New Material Corporation Information
 Table 204. Taihua New Material Description and Major Businesses
 Table 205. Taihua New Material Product Models, Descriptions and Specifications
 Table 206. Taihua New Material Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 207. Taihua New Material Recent Developments
 Table 208. Lu Thai Textile Corporation Information
 Table 209. Lu Thai Textile Description and Major Businesses
 Table 210. Lu Thai Textile Product Models, Descriptions and Specifications
 Table 211. Lu Thai Textile Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 212. Lu Thai Textile Recent Developments
 Table 213. Fynex Textile Corporation Information
 Table 214. Fynex Textile Description and Major Businesses
 Table 215. Fynex Textile Product Models, Descriptions and Specifications
 Table 216. Fynex Textile Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 217. Fynex Textile Recent Developments
 Table 218. Key Raw Materials Distribution
 Table 219. Raw Materials Key Suppliers
 Table 220. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 221. Milestones in Production Technology Evolution
 Table 222. Distributors List
 Table 223. Market Trends and Market Evolution
 Table 224. Market Drivers and Opportunities
 Table 225. Market Challenges, Risks, and Restraints
 Table 226. Research Programs/Design for This Report
 Table 227. Key Data Information from Secondary Sources
 Table 228. Key Data Information from Primary Sources


List of Figures
 Figure 1. Antiviral and Antibacterial Textiles Product Picture
 Figure 2. Global Antiviral and Antibacterial Textiles Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Inorganic Product Picture
 Figure 4. Organic Product Picture
 Figure 5. Global Antiviral and Antibacterial Textiles Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Daily Necessity
 Figure 7. Clothing
 Figure 8. Medical
 Figure 9. Others
 Figure 10. Antiviral and Antibacterial Textiles Report Years Considered
 Figure 11. Global Antiviral and Antibacterial Textiles Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Antiviral and Antibacterial Textiles Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Antiviral and Antibacterial Textiles Revenue Market Share by Region (2020-2031)
 Figure 15. Global Antiviral and Antibacterial Textiles Sales (2020-2031) & (Tons)
 Figure 16. Global Antiviral and Antibacterial Textiles Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global Antiviral and Antibacterial Textiles Sales Market Share by Region (2020-2031)
 Figure 18. Global Antiviral and Antibacterial Textiles Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 19. Global Antiviral and Antibacterial Textiles Production Trend by Region (2020-2031) (Tons)
 Figure 20. Global Antiviral and Antibacterial Textiles Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. Antiviral and Antibacterial Textiles Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 23. Antiviral and Antibacterial Textiles Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 24. Antiviral and Antibacterial Textiles Production Growth Rate in China (2020-2031) & (Tons)
 Figure 25. Antiviral and Antibacterial Textiles Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 26. Top 5 and Top 10 Manufacturers Antiviral and Antibacterial Textiles Sales Volume Market Share in 2024
 Figure 27. Global Antiviral and Antibacterial Textiles Revenue Market Share Ranking (2024)
 Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 29. Inorganic Revenue Market Share by Manufacturer in 2024
 Figure 30. Organic Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 33. Global Antiviral and Antibacterial Textiles Sales Market Share by Type (2020-2031)
 Figure 34. Global Antiviral and Antibacterial Textiles Revenue Market Share by Type (2020-2031)
 Figure 35. Global Antiviral and Antibacterial Textiles Sales Market Share by Application (2020-2031)
 Figure 36. Global Antiviral and Antibacterial Textiles Revenue Market Share by Application (2020-2031)
 Figure 37. North America Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
 Figure 38. North America Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. North America Top 5 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
 Figure 40. North America Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2020- 2031)
 Figure 41. North America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 42. North America Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
 Figure 43. North America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. US Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 45. Canada Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 46. Mexico Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 47. Europe Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
 Figure 48. Europe Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Europe Top 5 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
 Figure 50. Europe Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2020-2031)
 Figure 51. Europe Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Europe Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
 Figure 53. Europe Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Germany Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 55. France Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 59. Asia-Pacific Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
 Figure 60. Asia-Pacific Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Asia-Pacific Top 8 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
 Figure 62. Asia-Pacific Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2020- 2031)
 Figure 63. Asia-Pacific Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 64. Asia-Pacific Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
 Figure 65. Asia-Pacific Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Indonesia Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 67. Japan Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 68. South Korea Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 69. China Taiwan Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 70. India Antiviral and Antibacterial Textiles Revenue (2020-2031) & (US$ Million)
 Figure 71. Central and South America Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
 Figure 72. Central and South America Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Central and South America Top 5 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
 Figure 74. Central and South America Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2021-2031)
 Figure 75. Central and South America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Central and South America Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
 Figure 77. Central and South America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. Brazil Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
 Figure 79. Argentina Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
 Figure 80. Middle East, and Africa Antiviral and Antibacterial Textiles Sales YoY (2020-2031) & (Tons)
 Figure 81. Middle East and Africa Antiviral and Antibacterial Textiles Revenue YoY (2020-2031) & (US$ Million)
 Figure 82. Middle East and Africa Top 5 Manufacturers Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) in 2024
 Figure 83. Middle East and Africa Antiviral and Antibacterial Textiles Sales Volume (Tons) by Type (2021-2031)
 Figure 84. South America Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 85. Middle East and Africa Antiviral and Antibacterial Textiles Sales Volume (Tons) by Application (2020-2031)
 Figure 86. Middle East and Africa Antiviral and Antibacterial Textiles Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 87. GCC Countries Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
 Figure 88. Turkey Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
 Figure 89. Egypt Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
 Figure 90. South Africa Antiviral and Antibacterial Textiles Revenue (2020-2025) & (US$ Million)
 Figure 91. Antiviral and Antibacterial Textiles Industry Chain Mapping
 Figure 92. Regional Antiviral and Antibacterial Textiles Manufacturing Base Distribution (%)
 Figure 93. Antiviral and Antibacterial Textiles Production Process
 Figure 94. Regional Antiviral and Antibacterial Textiles Production Cost Structure
 Figure 95. Channels of Distribution (Direct Vs Distribution)
 Figure 96. Bottom-up and Top-down Approaches for This Report
 Figure 97. Data Triangulation
 Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart